Abstract
In this issue of Cell Chemical Biology, Bonazzi etal. demonstrate that pharmacologically degrading the transcription factor Helios (IKZF2) results in destabilization of regulatory Tcells, which normally restrain anti-tumor immunity. These results highlight how molecular glue degraders can selectively target previously undruggable proteins with potential applications in the clinic.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
